Pureland Group is a Singapore-based private investment group. We started our journey in 2014 from a single family office and grew to who we have become today. We currently have two investment portfolios: FUND Ⅰ focuses on secondary markets with capital preservation as its core theme FUND Ⅱ - Pureland Global Venture (PGV) is an impact driving Venture Capital fund which focuses on Medical Technology investments globally At PGV, impact runs in our blood and our mission is to bring medical access and saving to 100M people globally in the next 5 years especially emerging market. We look for companies which can inject value into the patient caring system, save lives and reduce supply-demand gap in healthcare systems. We believe that if a technology is solving a real problem, capital will flow in. Currently, we have portfolio companies invested in US, Europe, India and ASEAN. Some of our companies are backed by Gates foundation, Stanford University, America Colleague of Cardiology, etc.